These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37269373)

  • 1. Co-transient expression of PSA-Fc and PAP-Fc fusion protein in plant as prostate cancer vaccine candidates and immune responses in mice.
    Oh S; Kim K; Kang YJ; Hwang H; Kim Y; Hinterdorfer P; Kim MK; Ko K; Lee YK; Kim DS; Myung SC; Ko K
    Plant Cell Rep; 2023 Jul; 42(7):1203-1215. PubMed ID: 37269373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plant-derived PAP proteins fused to immunoglobulin A and M Fc domains induce anti-prostate cancer immune response in mice.
    Kang YJ; Kim DS; Kim S; Seo YJ; Ko K
    BMB Rep; 2023 Jul; 56(7):392-397. PubMed ID: 37037672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of leaf position and days post-infiltration on transient expression of colorectal cancer vaccine candidate proteins GA733-Fc and GA733-FcK in
    Kim K; Kang YJ; Park SR; Kim DS; Lee SW; Ko K; Ponndorf D; Ko K
    PeerJ; 2021; 9():e10851. PubMed ID: 33868796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune Responses to Plant-Derived Recombinant Colorectal Cancer Glycoprotein EpCAM-FcK Fusion Protein in Mice.
    Lim CY; Kim DS; Kang Y; Lee YR; Kim K; Kim DS; Kim MS; Ko K
    Biomol Ther (Seoul); 2022 Nov; 30(6):546-552. PubMed ID: 36263857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response of heterologous recombinant antigenic protein of viral hemorrhagic septicemia virus (VHSV) in mice.
    Shin C; Kang Y; Kim HS; Shin YK; Ko K
    Anim Cells Syst (Seoul); 2019 Apr; 23(2):97-105. PubMed ID: 30949396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of ELISA conditions to quantify colorectal cancer antigen-antibody complex protein (GA733-FcK) expressed in transgenic plant.
    Ahn J; Lee KJ; Ko K
    Monoclon Antib Immunodiagn Immunother; 2014 Feb; 33(1):1-7. PubMed ID: 24555929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosome targeting of tumor antigens expressed by cancer vaccines can improve antigen immunogenicity and therapeutic efficacy.
    Rountree RB; Mandl SJ; Nachtwey JM; Dalpozzo K; Do L; Lombardo JR; Schoonmaker PL; Brinkmann K; Dirmeier U; Laus R; Delcayre A
    Cancer Res; 2011 Aug; 71(15):5235-44. PubMed ID: 21670078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent systemic antitumor immunity induced by vaccination with chemotactic-prostate tumor associated antigen gene-modified tumor cell and blockade of B7-H1.
    Li N; Qin H; Li X; Zhou C; Wang D; Ma W; Lin C; Zhang Y; Wang S; Zhang S
    J Clin Immunol; 2007 Jan; 27(1):117-30. PubMed ID: 17180470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroids inversely affect the biosynthesis and secretion of human prostatic acid phosphatase and prostate-specific antigen in the LNCaP cell line.
    Henttu P; Vihko P
    J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):349-60. PubMed ID: 1373297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A vaccine strategy with multiple prostatic acid phosphatase-fused cytokines for prostate cancer treatment.
    Fujio K; Watanabe M; Ueki H; Li SA; Kinoshita R; Ochiai K; Futami J; Watanabe T; Nasu Y; Kumon H
    Oncol Rep; 2015 Apr; 33(4):1585-92. PubMed ID: 25632844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of GA733-Fc fusion protein as a vaccine candidate for colorectal cancer in transgenic plants.
    Lu Z; Lee KJ; Shao Y; Lee JH; So Y; Choo YK; Oh DB; Hwang KA; Oh SH; Han YS; Ko K
    J Biomed Biotechnol; 2012; 2012():364240. PubMed ID: 22675251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of PAP and PSA gene expression in prostatic hyperplasia and prostatic carcinoma using northern-blot analyses, in situ hybridization and immunohistochemical stainings with monoclonal and bispecific antibodies.
    Hakalahti L; Vihko P; Henttu P; Autio-Harmainen H; Soini Y; Vihko R
    Int J Cancer; 1993 Oct; 55(4):590-7. PubMed ID: 7691762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice.
    Karan D; Dubey S; Van Veldhuizen P; Holzbeierlein JM; Tawfik O; Thrasher JB
    Immunotherapy; 2011 Jun; 3(6):735-46. PubMed ID: 21668311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.
    Stamey TA; Yang N; Hay AR; McNeal JE; Freiha FS; Redwine E
    N Engl J Med; 1987 Oct; 317(15):909-16. PubMed ID: 2442609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in immunohistochemical staining of PSA, PAP, and TURP-27 following irradiation therapy for clinically localized prostate cancer.
    Grob BM; Schellhammer PF; Brassil DN; Wright GL
    Urology; 1994 Oct; 44(4):525-9. PubMed ID: 7524238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-dimensional characterization of prostatic acid phosphatase, prostatic specific antigen and prostate binding protein in expressed prostatic fluid.
    Lee C; Tsai Y; Sensibar J; Oliver L; Grayhack JT
    Prostate; 1986; 9(2):135-46. PubMed ID: 2428020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate-specific antigen as a marker of adenocarcinoma of prostate.
    Kellokumpu-Lehtinen P; Nurmi M; Koskinen P; Irjala K
    Urol Res; 1989; 17(4):245-9. PubMed ID: 2475959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of the immunochemical measurement of prostatic acid phosphatase and prostatic specific antigen in carcinoma of the prostate.
    Siddall JK; Cooper EH; Newling DW; Robinson MR; Whelan P
    Eur Urol; 1986; 12(2):123-30. PubMed ID: 2420600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naturally occurring prostate cancer antigen-specific T cell responses of a Th1 phenotype can be detected in patients with prostate cancer.
    McNeel DG; Nguyen LD; Ellis WJ; Higano CS; Lange PH; Disis ML
    Prostate; 2001 May; 47(3):222-9. PubMed ID: 11351352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prime-boost vaccination targeting prostatic acid phosphatase (PAP) in patients with metastatic castration-resistant prostate cancer (mCRPC) using Sipuleucel-T and a DNA vaccine.
    Wargowski E; Johnson LE; Eickhoff JC; Delmastro L; Staab MJ; Liu G; McNeel DG
    J Immunother Cancer; 2018 Mar; 6(1):21. PubMed ID: 29534736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.